“Compared with monotherapy, vitamin K combined with teriparatide significantly increased serum Gla-OC level and the number of osteoblast, decreased serum CTX-I level, reduced the number of osteoclasts and increased bone density and strength.”
“This study showed that the efficacy of vitamin K combined with teriparatide is better than that of monotherapy.”